When Chinese scientist Tu Youyou accepted the 2015 Nobel Prize in Physiology or Medicine, she stood as the first Chinese woman to receive this honor — but more importantly, she represented a discovery that has saved over 6 million lives from malaria since 2000, making artemisinin one of humanity’s most significant medical achievements of the modern era.
The Malaria Crisis: A Disease That Shaped History
Malaria has been one of humanity’s deadliest enemies throughout history. Transmitted through the bite of infected Anopheles mosquitoes, the disease has killed more people than all wars combined and has shaped the course of human civilization for millennia.
The Global Burden Before Artemisinin:
- Annual Cases: Over 300 million people infected each year in the 1990s
- Annual Deaths: More than 1 million deaths annually, mostly children under 5 in Africa
- Economic Impact: Estimated $12 billion lost annually in Africa alone
- Drug Resistance: By the 1960s, malaria parasites had developed resistance to chloroquine and other existing treatments
The situation was desperate. In Vietnam, more soldiers died from malaria than from combat during the war. In Africa, entire villages were being decimated. The World Health Organization had declared the failure of previous eradication efforts, and pharmaceutical companies had largely abandoned malaria research due to lack of profitability.
It was against this backdrop that China launched Project 523 in 1967 — a secret military research initiative named after its May 23 start date, with the mission to find new antimalarial drugs.
The Discovery: Ancient Wisdom Meets Modern Science
Tu Youyou, a researcher at the China Academy of Chinese Medical Sciences, was appointed head of the research group in 1969. With no advanced degrees or overseas training, she brought something perhaps more valuable: deep knowledge of traditional Chinese medicine and the determination to find answers in ancient texts.
The Breakthrough Process:
- 2000+ Herb Formulas: Tu’s team collected and tested over 2,000 traditional Chinese medicine preparations
- 640 Herbs: They identified 640 herbs with potential antimalarial properties
- 380 Extracts: They prepared and tested 380 extracts from these herbs
- Qinghao Discovery: Sweet wormwood (Artemisia annua, known in Chinese as qinghao) showed promise but inconsistent results
The turning point came when Tu discovered a 1,600-year-old text by Chinese alchemist Ge Hong, written around 340 CE. The text described a specific preparation method: “A handful of qinghao immersed in two liters of water, wring out the juice and drink it all.”
This was revolutionary insight. Standard extraction methods used boiling water, which Tu realized was destroying the active compound. Following Ge Hong’s guidance, she developed a low-temperature extraction method using ether — and the results were stunning.
The Result: The extract showed 100% effectiveness against malaria parasites in animal testing. In October 1971, Tu obtained the pure active compound, which was later named artemisinin (also called qinghaosu in Chinese).
In a remarkable demonstration of scientific courage, Tu tested the compound on herself first to ensure safety before clinical trials. The human trials that followed showed complete cure of malaria patients, with no apparent side effects.
How Artemisinin Works: A Revolutionary Mechanism
Artemisinin represents a completely new class of antimalarial drugs with a unique mechanism of action that took decades to fully understand.
The Science Behind Artemisinin:
- Peroxide Bridge: The molecule contains an unusual endoperoxide bridge (two oxygen atoms bonded together) that is key to its activity
- Iron Activation: When artemisinin encounters the high iron content in malaria-infected red blood cells, the peroxide bridge breaks
- Free Radical Attack: This generates highly reactive free radicals that attack and destroy the malaria parasite
- Selective Toxicity: The mechanism specifically targets infected cells, leaving healthy cells largely unharmed
Why Artemisinin Is Special:
- Rapid Action: Kills parasites faster than any other antimalarial drug — patients often feel better within hours
- All Stages: Effective against all blood stages of the malaria parasite, including the ring stage
- Gametocyte Reduction: Reduces transmission by killing the sexual forms of the parasite
- Synergy: Works effectively in combination with other antimalarial drugs
This last point led to the development of Artemisinin-Based Combination Therapies (ACTs), which combine artemisinin with a partner drug with longer half-life. ACTs have become the gold standard for malaria treatment worldwide, recommended by WHO since 2006.
Global Impact: Saving Millions of Lives
The numbers tell the story of artemisinin’s extraordinary impact on global health:
Lives Saved:
- Since 2000: Over 6 million lives saved, according to WHO estimates
- Mortality Reduction: Global malaria deaths decreased by 60% between 2000 and 2019
- African Impact: Malaria mortality rates in Africa fell by 66% in children under 5
- Cases Prevented: An estimated 1.5 billion malaria cases treated successfully with ACTs
Geographic Reach:
- Countries Using ACTs: Over 80 malaria-endemic countries have adopted ACTs as first-line treatment
- Doses Distributed: Billions of ACT treatment courses distributed globally
- Chinese Production: China supplies a significant portion of the world’s artemisinin, with exports to African nations alone valued at over $30 million annually
The impact extends beyond statistics. In villages across Africa, artemisinin has meant the difference between life and death for mothers watching their children suffer from high fevers. In Southeast Asia, it has enabled workers to stay productive instead of losing weeks to illness. For entire communities, it has meant hope where there was once only despair.
China’s Ongoing Contribution to Global Health
China’s contribution to global malaria control extends far beyond the initial discovery of artemisinin. The country has emerged as a leader in malaria elimination and continues to support global health initiatives.
China’s Malaria Elimination Success:
- 2021 Milestone: WHO certified China as malaria-free in June 2021
- From 30 Million to Zero: China reduced annual cases from 30 million in the 1940s to zero indigenous cases
- 70-Year Journey: Achieved through sustained government commitment, community mobilization, and innovative strategies
- Model for Others: China’s experience now guides other countries’ elimination efforts
Global Health Initiatives:
- Artemisinin Supply: China maintains stable production and affordable pricing for global distribution
- Technology Transfer: Chinese companies have partnered with African nations to establish local ACT production facilities
- Training Programs: Chinese medical teams have trained thousands of healthcare workers in endemic countries
- Research Collaboration: Ongoing partnerships with WHO and international research institutions to improve treatments
Addressing Resistance:
When artemisinin-resistant malaria strains emerged in Southeast Asia in the 2000s, Chinese researchers were at the forefront of the response. They helped develop new ACT combinations and treatment protocols to overcome resistance, demonstrating continued commitment to protecting this life-saving drug.
The Future: Toward Malaria Elimination
The success of artemisinin has transformed the global fight against malaria from control to elimination. But challenges remain, and China continues to play a crucial role.
Current Challenges:
- Resistance: Artemisinin-resistant parasites have been detected in parts of Southeast Asia, requiring vigilant monitoring and new drug combinations
- Access Gaps: Many in remote endemic areas still lack access to effective treatment
- Climate Change: Warming temperatures are expanding mosquito habitats to new regions
- Funding: Global malaria programs face chronic underfunding
China’s Role in the Future:
- New Drug Development: Chinese researchers are developing next-generation artemisinin derivatives and new antimalarial compounds
- Vaccine Support: China has contributed to RTS,S/AS01 malaria vaccine development and deployment
- Surveillance Systems: Sharing expertise in surveillance and rapid response to outbreaks
- Belt and Road Health Initiative: Integrating malaria control into broader health cooperation with partner countries
WHO’s 2030 Targets:
- Reduce malaria case incidence by at least 90%
- Reduce malaria mortality rates by at least 90%
- Eliminate malaria in at least 35 countries
- Prevent re-establishment of malaria in all countries that are malaria-free
The journey from ancient Chinese medical texts to modern Nobel Prize recognition exemplifies the power of combining traditional knowledge with scientific rigor. Tu Youyou’s discovery, made in relative obscurity during a difficult period in China’s history, has become one of humanity’s shared treasures — a gift from China to the world that continues to save lives every day.
As Tu said in her Nobel lecture: “Artemisinin is a gift to the world from traditional Chinese medicine.” It is also a reminder that solutions to humanity’s greatest challenges may lie not only in cutting-edge technology but also in the wisdom of our ancestors, waiting to be rediscovered.